The FASTKD2 gene helps mitochondria, the parts of cells that make energy, handle the genetic messages needed to keep energy production running. If it does not work properly, cells may struggle to make enough energy, especially in the brain and muscles. Pathogenic variants in both copies of the FASTKD2 gene can cause a mitochondrial condition linked to developmental delay, seizures, weakness, and sometimes lactic acidosis, a buildup of acid in the blood. Most people learn about FASTKD2 through genetic testing for unexplained neurologic or metabolic symptoms.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
FASTKD2Gene function
What if the gene works
The FASTKD2 gene helps mitochondria, the parts of cells that make energy, handle genetic messages. This supports steady energy production, especially in tissues with high energy needs like the brain and muscles.
Risk
What if the gene does not work
Variants in the FASTKD2 gene can impair mitochondrial energy production. More severe variants are linked to mitochondrial disease, often with developmental delay, seizures, weakness, or stroke-like episodes, while milder variants may cause a later or less severe picture.
Treatment
What does that mean for your treatment
No FASTKD2-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the FASTKD2 gene. Care is guided by symptoms rather than by a gene-specific drug choice. Early research is exploring how the FASTKD2 gene affects mitochondrial disease, but this has not yet led to a targeted therapy.
Conditions associated with FASTKD2
Gene function
What if the gene works
Much of your day to day energy depends on mitochondria, the parts of cells that make energy. Inside these structures, the FASTKD2 gene helps organize RNA instructions so mitochondria can build the proteins they need. This steady behind the scenes work supports normal energy production across the body.
Inside mitochondria, the FASTKD2 gene helps manage RNA, the working copies of genetic instructions. This supports the proper shaping and stability of messages needed for energy making proteins.
FASTKD2 supports the mitochondrial system that reads RNA messages and builds key proteins. These proteins help the cell's energy machinery run in an organized, steady way.
By helping mitochondria process RNA and make proteins, the FASTKD2 gene supports everyday energy production. This matters most in tissues that use a lot of energy, such as muscles, the brain, and the heart.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help account for normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FASTKD2 gene can shorten or destabilize the protein, weaken its RNA binding, or reduce how much of it reaches mitochondria. This can impair mitochondrial RNA processing and lower oxidative phosphorylation (the cell's energy making system). Milder variants may leave partial activity, while more severe variants can cause near complete loss of function and are often linked to earlier, more pronounced mitochondrial disease.
How variants are linked to conditions
Pathogenic variants in the FASTKD2 gene can cause combined oxidative phosphorylation deficiency 46, a rare mitochondrial condition. In this FASTKD2 gene condition link, affected people may have developmental delay, seizures, muscle weakness, feeding difficulties, or episodes that affect the brain, and severity can vary. Some reported cases also include hearing or vision problems.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the FASTKD2 gene. For many living with a FASTKD2 change, risk depends mainly on the exact genetic change and whether both copies of the gene are affected, rather than on lifestyle or everyday exposures.
Inheritance of FASTKD2 variants
For the known condition linked to the FASTKD2 gene, the FASTKD2 inheritance pattern is autosomal recessive. This means a child usually inherits one nonworking copy of the gene from each parent. Parents who each carry one FASTKD2 gene variant are often unaffected, and with each pregnancy there is a 25% chance the child inherits both altered copies, a 50% chance the child is a carrier, and a 25% chance the child inherits neither variant. This pattern affects sons and daughters equally.
What does my FASTKD2 result mean for my family?
FASTKD2-related disease is typically inherited in a recessive way, so family members are most often healthy carriers unless they also have two changed copies of the gene. Brothers and sisters of someone with a confirmed FASTKD2-related condition may also be affected or be carriers, and parents are usually carriers. More distant relatives can sometimes carry the same gene change too, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the FASTKD2 gene, genetic testing for FASTKD2 variants uses a blood or saliva sample to read your DNA. A lab checks the FASTKD2 gene for variants and reports whether one was found, which can help explain whether your symptoms fit a FASTKD2 related condition.
When should I consider getting a genetic test?
Genetic testing for the FASTKD2 gene may be considered when a child or adult has signs of a rare inherited condition linked to problems with how cells make energy, such as developmental delay, seizures, muscle weakness, or hearing problems. It can also help when there is a family history of a similar mitochondrial condition.
A genetic result is only one part of your health story
Genetic results can be informative, although what they can tell you varies with the condition and the kind of variant involved. Over time, the body is also shaped by factors like lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help explain individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This kind of difference is common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies the relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. If you want to learn more about this topic, you can read further in the LearnHub.
Drugs influenced by the FASTKD2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how people respond to medicines, so questions about side effects, new symptoms, or medication changes are best discussed with your doctor or pharmacist.
History
In recent decades, awareness of this gene’s role has grown. The FASTKD2 gene came to medical attention as researchers studied a family with a rare mitochondrial condition affecting brain development and energy use, with reports appearing in the early 2010s. That finding helped place FASTKD2 among a small group of related genes linked to mitochondrial disease. From these first observations, research expanded steadily. Scientists then began identifying additional FASTKD2 variants in people with a range of mitochondrial symptoms, which broadened the clinical picture. Over time, descriptions became more precise as genetic sequencing became more widely used in both research and patient care.